Optimum Investment Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-100
| Closed | -$18K | – | 949 |
|
|
2021
Q2 | $18K | Hold |
100
| – | – | 0.01% | 677 |
|
|
2021
Q1 | $15K | Hold |
100
| – | – | ﹤0.01% | 719 |
|
|
2020
Q4 | $16K | Hold |
100
| – | – | ﹤0.01% | 664 |
|
|
2020
Q3 | $11K | Hold |
100
| – | – | ﹤0.01% | 696 |
|
|
2020
Q2 | $11K | Hold |
100
| – | – | ﹤0.01% | 691 |
|
|
2020
Q1 | $9K | Hold |
100
| – | – | ﹤0.01% | 705 |
|
|
2019
Q4 | $11K | Hold |
100
| – | – | ﹤0.01% | 768 |
|
|
2019
Q3 | $10K | Hold |
100
| – | – | ﹤0.01% | 808 |
|
|
2019
Q2 | $13K | Hold |
100
| – | – | ﹤0.01% | 743 |
|
|
2019
Q1 | $14K | Hold |
100
| – | – | ﹤0.01% | 756 |
|
|
2018
Q4 | $10K | Hold |
100
| – | – | ﹤0.01% | 766 |
|
|
2018
Q3 | $14K | Hold |
100
| – | – | ﹤0.01% | 801 |
|
|
2018
Q2 | $12K | Hold |
100
| – | – | ﹤0.01% | 824 |
|
|
2018
Q1 | $11K | Buy |
+100
| New | +$12K | ﹤0.01% | 816 |
|
|
2015
Q1 | $17K | Hold |
100
| – | – | 0.01% | 727 |
|
|
2014
Q4 | $19K | Hold |
100
| – | – | 0.01% | 738 |
|
|
2014
Q3 | $17K | Hold |
100
| – | – | 0.01% | 681 |
|
|
2014
Q2 | $16K | Hold |
100
| – | – | 0.01% | 703 |
|
|
2014
Q1 | $15K | Hold |
100
| – | – | 0.01% | 553 |
|
|
2013
Q4 | $13K | Hold |
100
| – | – | ﹤0.01% | 580 |
|
|
2013
Q3 | $12K | Buy |
+100
| New | +$11K | ﹤0.01% | 564 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM